The role of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tub

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：zjj008

【摘要】

：

　　Objective: The effects of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tuberculosis has not been known well.The aim

【作者】

：

QingmingShi;MeiChai;

【机构】

：

Oncology, Anhui chest hospital

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: The effects of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tuberculosis has not been known well.The aim of this study was to investigate the curative and side effects of antitubereulosis treatment in lung cancer patients with co-morbid pulmonary tuberculosis.

其他文献

Depression Reduces Progression-free Survival of Platinum-based Chemotherapy in Patients with Lung Ad

　　Objective: As a poor prognostic cancer, lung cancer which has serious impact on psychological of patients.The patient offen involed in a state of depression

会议

Different Adaptive Response Induced by Low-dose Radiation in Normal Lung Cells and Lung Cancer Cells

　　Objective: Low-dose radiation (LDR) has been proposed to induce an adaptive response in normal cells but not in tumor cells, which may protect normal tissue

会议

Prognostic significance of KRT 19 in lung cancer

　　Objective: Lung cancer is a heterogeneous group of malignancies with variable prognosis and is divided into two main groups, small cell lung cancer (SCLC) a

会议

Notch3 promotes chemoresistance by upregulting ALDH1 A1 and CD44 and induces autophagy in non-small

　　Objective: Acquiredresistance to standard chemotherapy causes treatment failure in patients with advanced non-small lung cancer (NSCLC).Cancer stem cells (C

会议

The treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the pati

　　Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced

会议

Serum microRNA-139-5p is a biomarker of bone metastasis in lung cancer patient

　　Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the cou

会议

miR-1285-3p plays a tumor suppressor role in NSCLC by targeting YAP1

　　Objective: Non small cell lung cancer (NSCLC) is one of the most aggressive types of cancer and the leading cause of cancer mortality, yet the pathologic me

会议

Analysis of Prognostic Factors in 154 Patients with Small Cell Lung Cancer

　　Objective: To evaluate the survival of patients with small cell lung cancer and analyze the prognostic factors in these patients.Method: Clinical data were

会议

MiR-326 regulates cell proliferation and migration in lung cancer by targeting Phox2a and is regulat

　　Objective: MicroRNA plays a crucial role in development and progression of multiple malignancies.However, the mechanisms of microRNA in cancer are not total

会议

Combination of Angiogenesis Inhibitor (Endostar) and EGFR-TKIs in Patients with Advanced Non-small c

　　Objective: To evaluate the clinical activity of angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib

会议

The role of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tub

与本文相关的学术论文